CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination
Article in Journal of Nanobiotechnology (January 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
PTEN Deficiency in Tubo-Ovarian High-Grade Serous Carcinoma is Associated with Poor Progression-Free Survival and is Mutually Exclusive with CCNE1 Amplification
Article in Modern Pathology (February 2023)
Protein degradation: expanding the toolbox to restrain cancer drug resistance
Article in Journal of Hematology & Oncology (January 2023)